FIRST QUADRANT LLC/CA - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 204 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 16.41 and the average weighting 0.1%.

Quarter-by-quarter ownership
FIRST QUADRANT LLC/CA ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2021$36,000
+227.3%
1,562
+178.9%
0.00%
+300.0%
Q4 2020$11,000
+22.2%
560
+21.0%
0.00%0.0%
Q3 2020$9,000
-97.2%
463
-96.8%
0.00%
-97.7%
Q2 2020$324,000
+383.6%
14,435
+326.1%
0.04%
+760.0%
Q4 2018$67,000
+4.7%
3,388
-1.9%
0.01%
+400.0%
Q4 2016$64,000
-92.4%
3,452
-92.2%
0.00%
-94.4%
Q3 2016$842,00044,3690.02%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q1 2022
NameSharesValueWeighting ↓
FRIESS ASSOCIATES LLC 97,760$3,401,0005.68%
Nantahala Capital Management 1,000,000$34,790,0001.74%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 341,294$11,874,0001.52%
Portolan Capital Management 274,889$9,563,0000.96%
Quantedge Capital Pte Ltd 121,500$4,227,0000.85%
SHAKER INVESTMENTS LLC/OH 37,117$1,291,0000.82%
GLOBEFLEX CAPITAL L P 72,253$2,514,0000.61%
EAM Investors, LLC 68,855$2,395,0000.58%
Hillsdale Investment Management Inc. 197,738$6,879,0000.55%
Capital Impact Advisors, LLC 13,835$481,0000.44%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders